妊娠期或妊娠前接受治疗的胶质瘤患者的妊娠与新生儿结局:单机构回顾性系列
妊娠期诊断组8例中7例孕期接受治疗,所有妊娠无显著母体并发症且分娩健康新生儿;妊娠前诊断组13例共18次妊娠分娩,3/18次妊娠并发癫痫发作,5/18次妊娠后代出现无功能影响的解剖异常。
要点
- 妊娠期诊断胶质瘤并接受治疗者母胎结局总体良好
- 妊娠前诊断组后代解剖异常率高于预期但无功能影响
- 替莫唑胺暴露后代解剖异常4/13(31%),未暴露1/5(20%)
核心结论
- 妊娠前或妊娠期诊断胶质瘤与总体良好的母体、胎儿及儿童期结局相关。
- 诊断后妊娠队列观察到解剖异常率高于预期,但均无有意义的功能后果。
研究设计与样本
- 队列A为妊娠期诊断胶质瘤的8例患者,其中7例在妊娠期接受胶质瘤治疗。
- 队列B为既往诊断胶质瘤后妊娠的13例患者,共18次妊娠并分娩新生儿。
主要发现
- 队列A所有妊娠均无显著母体并发症,且均分娩健康新生儿。
- 队列B中3/18次妊娠的产前病程并发癫痫发作。
- 队列B后代中5/18次妊娠出现无功能影响的解剖异常。
- 替莫唑胺暴露后代解剖异常发生率为4/13(31%),未暴露后代为1/5(20%)。
临床怎么用
- 为妊娠期或妊娠前诊断胶质瘤的患者提供咨询时,可参考本系列中总体良好的母胎结局。
- 对妊娠前有胶质瘤诊断且曾接受替莫唑胺治疗者,应告知后代解剖异常信号但无功能影响。
局限性
- 原文未报告统计比较或长期发育随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma diagnosed during pregnancy and pregnancy following glioma treatment present complex management challenges. Safety of glioma treatment during pregnancy is not well established. The ability to counsel patients on timing of conception after treatment remains limited. The aim of this study was to describe our institution's experience with pregnancy during and/or after treatment for glioma. METHODS: In this single-institution study, we retrospectively identified patients diagnosed with glioma during or prior to pregnancy and described treatment courses and maternal and neonatal outcomes. RESULTS: Twenty-one female patients were included. Glioma diagnoses included 12 high-grade tumors and 9 low-grade tumors. Cohort A consisted of 8 patients who presented with glioma during pregnancy, of which, 7 underwent glioma treatment during pregnancy. All pregnancies in cohort A were without significant maternal complications and resulted in delivery of a healthy neonate. Cohort B consisted of 13 patients who experienced pregnancy after a prior diagnosis of glioma, totaling 18 pregnancies that resulted in delivery of a neonate. Antepartum course was complicated by seizure in 3/18 pregnancies. Functionally inconsequential anatomic abnormalities in childhood offspring of cohort B occurred in 5/18 pregnancies. Anatomic abnormalities occurred in 4/13 (31%) of temozolomide exposed offspring and 1/5 (20%) of temozolomide unexposed offspring. CONCLUSIONS: In this retrospective series, diagnosis of glioma before or during pregnancy was associated with generally favorable maternal, fetal and childhood outcomes. We observed higher-than-expected rate of anatomic abnormalities in the post-diagnosis cohort, though none carried meaningful functional consequences. These findings add to the limited literature exploring pregnancy outcomes in patients with glioma.
引用
- Valerius AR, Strathman A, Rodriguez AE, et al. Pregnancy and neonatal outcomes in patients treated for glioma before or during pregnancy: a single-institution retrospective series. J Neurooncol. 2026. PMID: 42658311. doi:10.1007/s11060-026-05765-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。